Prices of Levofloxacin Hemihydrate: In the second quarter of 2023 | ChemAnalyst

Prices of Levofloxacin Hemihydrate: In the second quarter of 2023 | ChemAnalyst

For the Quarter Ending June 2023

North America:

Within the United States, the pricing landscape for Levofloxacin Hemihydrate witnessed a 1.70 percent increase in June compared to the levels observed in April. This uptrend was notably influenced by several factors. The US manufacturing PMI, a critical indicator of market dynamics, experienced a decline to 46.3 in June from 48.4 in May and 47.1 in April. This contraction underscored the presence of limited inventories among market suppliers and traders, accompanied by delivery delays by suppliers aiming to meet robust consumer demand. Such conditions lent support to the upward trajectory of Levofloxacin Hemihydrate prices. Additionally, the rise in market sentiment was attributed to heightened consumer interest and a concurrent scarcity of supply. These factors collectively compelled traders to revise their quotations upward and prioritize restocking efforts. While the consumer price index (CPI) indicated a 0.2 percent increase in June compared to the 0.1 percent observed in May, it also signaled a moderation in inflation due to interest rate hikes by the US Federal Reserve. Despite this moderation, prices remained elevated, implying the potential for further rate hikes in the third quarter. Furthermore, consistent import momentum played a stabilizing role, supporting the Levofloxacin Hemihydrate market's trajectory during the second quarter.

Asia Pacific:

In China, the pricing dynamics of Levofloxacin Hemihydrate underwent a 0.99 percent increase in June compared to the levels recorded in April. The elevated pricing trend within the second quarter was attributed to multiple factors. Elevated demand from end consumers and diminished inventories among market providers were key drivers. Furthermore, higher upstream costs, coupled with initiatives to replenish inventories with fresh stock in anticipation of future demand, lent significant support to the robustness of the Levofloxacin Hemihydrate market. The official manufacturing Purchasing Managers' Index of China, settling at 49.0 in June from 48.8 in May and 49.2 in April, indicated a decline in factory activity for the third consecutive month, leading to a shortage of inventories amid a positive demand outlook. This scarcity further contributed to maintaining prices at higher levels. The continued operational activity of production plants, combined with growing inquiries from importers and traders, exerted upward pressure on domestic market production costs, further driving the elevation of Levofloxacin Hemihydrate prices across the Chinese market.

Levofloxacin Hemihydrate Prices: https://www.chemanalyst.com/Pricing-data/levofloxacin-hemihydrate-1401

Europe:

In Germany, the pricing paradigm for Levofloxacin Hemihydrate experienced a notable 2.04 percent increase in June from the levels noticed in April. The driving forces behind this upward trajectory were rooted in domestic demand dynamics and overall supply conditions among domestic merchants. Furthermore, the market in Germany benefited from new production initiatives in exporting nations, responding to heightened demand and the backdrop of elevated energy prices. Notably, Germany's manufacturing Purchasing Managers Index (PMI) exhibited a decline to 41 in June from 43.2 in May and 44.5 in April. This contraction reflected reduced business activity, fewer inventories among market traders and suppliers, and shipment delays aimed at meeting heightened demand, collectively contributing to elevated prices for levofloxacin hemihydrate. Additionally, burgeoning demand from the end-use sector provided further impetus to the upward trend in levofloxacin hemihydrate prices. As inflation escalated by 6.4 percent in June and energy prices surged by 3 percent, businesses reliant on active pharmaceutical ingredients (APIs) encountered escalated costs. This subsequent escalation in costs propelled the prices of Levofloxacin Hemihydrate to higher levels.

?

About Us:?

?

ChemAnalyst?is a subsidiary of TechSci Research, which was established in 2008, and has been providing exceptional management consulting to its clients across the globe for over a decade now. For the past four years, ChemAnalyst has been a prominent provider of Chemical commodity prices in more than 15 countries. We are a team of more than 100 Chemical Analysts who are committed to provide in-depth market insights and real-time price movement for 300+ chemical and petrochemical products. ChemAnalyst has reverberated as a preferred pricing supplier among Procurement managers and Strategy professionals worldwide. On our platform, we provide an algorithm-based subscription where users can track and compare years of historical data and prices based on grades and incoterms (CIF, CFR, FOB, & EX-Works) in just one go.

?

Contact Us:

ChemAnalyst

420 Lexington Avenue, Suite 300,

New York, NY, United States, 10170

Call +1 3322586602

Email:?[email protected]

Website:?https://www.chemanalyst.com

要查看或添加评论,请登录

Ganesh Kumar的更多文章

社区洞察

其他会员也浏览了